Favorable Maternal and Fetal Effects of Danshensu in an Experimental Mice Model of Preeclampsia

REFERENCES

• Sibai BM. Imitators of severe pre-eclampsia. Semin Perinatol 2009; 33:196–205.
   PubMed Web of Science ®Google Scholar
• Brenner B, Aharon A. Thrombophilia and adverse pregnancy outcome. Clin Perinatol 2007; 34:527–541, v.
   Google Scholar
• Roberts DJ, Post MD. The placenta in pre-eclampsia and intrauterine growth restriction. J Clin Pathol 2008; 61:1254–1260.
   PubMed Web of Science ®Google Scholar
• Gilbert JS, Ryan MJ, LaMarca BB, Sedeek M, Murphy SR, Granger JP. Pathophysiology of hypertension during preeclampsia: Linking placental ischemia with endothelial dysfunction. Am J Physiol Heart Circ Physiol 2008; 294:H541–H550.
   PubMed Web of Science ®Google Scholar
• Omatsu K, Kobayashi T, Murakami Y, Phosphatidylserine/phosphatidylcholine microvesicles can induce preeclampsia-like changes in pregnant mice. Semin Thromb Hemost 2005; 31:314–320.
   Google Scholar
• Saisto T, Tiitinen A, Ulander VM, Kaaja R. Clinical cure of severe, early onset preeclampsia with low molecular weight heparin therapy in primigravida with hyperreactio luteinalis and thrombophilia. Hum Reprod 2004; 19:725–728.
   Google Scholar
• Vormittag R, Pabinger I. Thrombophilia and pregnancy complications. Hamostaseologie 2006; 26:59–62.
   Google Scholar
• Askie LM, Duley L, Henderson-Smart DJ, Stewart LA, PARIS Collaborative Group. Antiplatelet agents for prevention of pre-eclampsia: A meta-analysis of individual patient data. Lancet 2007; 369:1791–1798.
   PubMed Web of Science ®Google Scholar
• Ruano R, Fontes RS, Zugaib M. Prevention of preeclampsia with low-dose aspirin-a systematic review and meta-analysis of the main randomized controlled trials. Clinics 2005; 60:407–414.
   PubMedGoogle Scholar
• McCoy S, Baldwin K. Pharmacotherapeutic options for the treatment of preeclampsia. Am J Health Syst Pharm 2009; 66:337–344.
   Web of Science ®Google Scholar
• Zhou L, Zuo Z, Chow MS. Danshen: An overview of its chemistry, pharmacology, pharmacokinetics, and clinical use. J Clin Pharmacol 2005; 45:1345–1359.
   PubMed Web of Science ®Google Scholar
• Adams JD, Wang R, Yang J, Lien EJ. Preclinical and clinical examinations of Salvia miltiorrhiza and its tanshinones in ischemic conditions. Chin Med 2006; 1:663–694.
   Google Scholar
• Du XH, Jiang L, Jiang XQ. Study on therapeutic mechanisms of Danshen injection in intrahepatic cholestasis of pregnancy. Zhongguo Zhong Yao Za Zhi 2006; 31(11):921–923.
   Google Scholar
• Ogawa H, Yonezawa S, Maruyama I, Expression of thrombomodulin in squamous cell carcinoma of the lung: Its relationship to lymph node metastasis and prognosis of the patients. Cancer Lett 2000; 149:95–103.
   PubMed Web of Science ®Google Scholar
• Swaab DF, Dubelaar EJ, Scherder EJ, van Someren EJ, Verwer RW. Therapeutic strategies For Alzheimer disease: Focus on neuronal reactivation of metabolically impaired neurons. Alzheimer Dis Assoc Disord 2003; l7:S114–S122.
   Google Scholar
• Zhang Y, Hua Z, Zhang K, Meng K, Hu Y. Therapeutic effects of anticoagulant agents on preeclampsia in a murine model induced by phosphatidylserine/phosphatidylcholine microvesicles. Placenta 2009; 30:1065–1070.
   PubMed Web of Science ®Google Scholar
• VanWijk MJ, Boer K, Berckmans RJ, Enhanced coagulation activation in preeclampsia: The role of APC resistance, microparticles and other plasma constituents. Thromb Haemost 2002; 88:415–420.
   PubMed Web of Science ®Google Scholar
• Wang Y, Gu Y, Zhang Y, Lewis DF. Evidence of endothelial dysfunction in preeclampsia: Decreased endothelial nitric oxide synthase expression is associated with increased cell permeability in endothelial cells from preeclampsia. Am J Obstet Gynecol 2004; 190:817–824.
   PubMed Web of Science ®Google Scholar
• Heilmann L, Rath W, Pollow K. Haemostatic abnormalities in patients with severe preeclampsia. Clin Appl Thromb Hemost 2007; 13:285–291.
   PubMed Web of Science ®Google Scholar
• Burton GJ, Yung HW, Cindrova-Davies T, Placental endoplasmic reticulum stress and oxidative stress in the pathophysiology of unexplained intrauterine growth restriction and early onset preeclampsia. Placenta 2009; 30:S43–S48.
   PubMed Web of Science ®Google Scholar
• Ness RB, Sibai BM. Shared and disparate components of the pathophysiologies of fetal growth restriction and preeclampsia. Am J Obstet Gynecol 2006; 195:40–49.
   PubMed Web of Science ®Google Scholar
• Knight M, Duley L, Henderson-Smart DJ, King JF. WITHDRAWN: Antiplatelet agents for preventing and treating pre-eclampsia. Cochrane Database Syst Rev 2007; 18:CD000492.
   Google Scholar
• Le Templier G, Rodger MA. Heparin-induced osteoporosis and pregnancy. Curr Opin Pulm Med 2008; 14:403–407.
   PubMed Web of Science ®Google Scholar
• Kelton JG, Warkentin TE. Heparin-induced thrombocytopenia: A historical perspective. Blood 2008; 112:2607–2616.
   PubMed Web of Science ®Google Scholar
• Duley L. Pre-eclampsia and the hypertensive disorders of pregnancy. Br Med Bull 2003; 67:161–176.
   PubMed Web of Science ®Google Scholar
• Lam FF, Yeung JH, Chan KM, Or PM. Relaxant effects of danshen aqueous extract and its constituent danshensu on rat coronary artery are mediated by inhibition of calcium channels. Vascul Pharmacol 2007; 46:271–277.
   PubMed Web of Science ®Google Scholar
• Zhao GR, Zhang HM, Ye TX, Characterization of the radical scavenging and antioxidant activities of danshensu and salvianolic acid B. Food Chem Toxicol 2008; 46:73–81.
   PubMed Web of Science ®Google Scholar
• Chan K, Chui SH, Wong DY, Ha WY, Chan CL, Wong RN. Protective effects of danshensu from the aqueous extract of Salvia miltiorrhiza (Danshen) against homocysteine-induced endothelial dysfunction. Life Sci 2004; 75:3157–3171.
   PubMed Web of Science ®Google Scholar
• Ding M, Yuan YJ. Study on the mechanisms of an extract of Salvia miltiorrhiza on the regulation of permeability of endothelial cells exposed to tumour necrosis factor-α. J Pharm Pharmacol 2007; 59:1027–1033.
   Google Scholar
• Guo GQ, Shen WZ, Zhong SZ. Induction effect of danshensu and salvianolic acid on the migration of
   Google Scholar
• Chu H, Shen M. Treating oligohydramnios with extract of Salvia miltiorrhiza: A randomized control trial. Ther Clin Risk Manag 2008; 4:287–290.
   PubMedGoogle Scholar